Wednesday, December 02, 2020 10:32:48 AM
I agree they should work harder at becoming more transparent and offering real revenues and guidance, but they trade on the otc for a reason and aren’t bound to report. Maybe investor expectations were curbed and many are selling off, or maybe there is more to this move. If institutional buying occurred, as you stated, they surely aren’t selling because an imaginary reporting deadline was missed. Idk, but clearly those holding such as myself aren’t happy about it.
Recent LKNCY News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 11:24:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:34:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 12:00:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 04:40:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/16/2023 11:30:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 11:35:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/10/2023 02:28:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2023 09:09:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 11:00:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/07/2023 02:31:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2023 11:35:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:09:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:03:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM